Samson Medical Technologies, LLC

For Samson Medical Technologies, LLC, import alert is 66-57; import alert name is "Detention Without Physical Examination of Foreign Manufactured Unapproved Prescription Drugs Distributed to Individuals in the U.S."; country is UNITED STATES; address is 1815 Garden Ave , Cherry Hill, NJ 08003-2303 UNITED STATES; date published is 09/10/2009, recorded from its source on 2026-08-06.

What the source says

Samson Medical Technologies, LLC Date Published : 09/10/2009 1815 Garden Ave , Cherry Hill, NJ 08003-2303 UNITED STATES 55 - - - -- Pharm Necess & Ctnr For Drug/Bio Date Published: 03/02/2021 Desc: All prescription drugs (finished dosage form) Notes: 10/16/2006 ;Note: On December 1, 2005, a Warning Letter was issued to Samson Medical Technologies for importing and marketing unapproved antibiotic drug products. The products may be offered for entry labeled as �sterile bulk� and �For pharmacy compounding only�, although the articles are in fact finished pharmaceuticals. Currently Samson does not hold approved applications for all these products. Districts should contact CDER Import-Export Team if they have any questions about the regulatory status of the products. Note changed - 6/5/2007 56 - - - -- Antibiotics (Human/Animal) Date Published: 09/10/2009 Notes: All prescription drugs (finished dosage form) - 10/16/2006 Note: On December 1, 2005, a Warning Letter was issued to Samson Medical Technologies for importing and marketing unapproved antibiotic drug products. The products may be offered for entry labeled as �sterile bulk� and �For pharmacy compounding only�, although the articles are in fact finished pharmaceuticals. Currently Samson does not hold approved applications for all these products. Districts should contact CDER Import-Export Team if they have any questions about the regulatory status of the products. Note changed - 6/5/2007 58 - - - -- Human and Animal Therapeutic Biologic and Biosimilar Drugs Date Published: 05/26/2022 60 - - - -- Human and Animal Drugs Date Published: 09/10/2009 Notes: All prescription drugs (finished dosage form) - 10/16/2006 Note: On December 1, 2005, a Warning Letter was issued to Samson Medical Technologies for importing and marketing unapproved antibiotic drug products. The products may be offered for entry labeled as �sterile bulk� and �For pharmacy compounding only�, although the articles are in fact finished pharmaceuticals. Currently Samson does not hold approved applications for all these products. Districts should contact CDER Import-Export Team if they have any questions about the regulatory status of the products. Note changed - 6/5/2007 61 - - - -- Human and Animal Drugs Date Published: 09/10/2009 Notes: All prescription drugs (finished dosage form) - 10/16/2006 Note: On December 1, 2005, a Warning Letter was issued to Samson Medical Technologies for importing and marketing unapproved antibiotic drug products. The products may be offered for entry labeled as �sterile bulk� and �For pharmacy compounding only�, although the articles are in fact finished pharmaceuticals. Currently Samson does not hold approved applications for all these products. Districts should contact CDER Import-Export Team if they have any questions about the regulatory status of the products. Note changed - 6/5/2007 62 - - - -- Human and Animal Drugs Date Published: 09/10/2009 Notes: All prescription drugs (finished dosage form) - 10/16/2006 Note: On December 1, 2005, a Warning Letter was issued to Samson Medical Technologies for importing and marketing unapproved antibiotic drug products. The products may be offered for entry labeled as �sterile bulk� and �For pharmacy compounding only�, although the articles are in fact finished pharmaceuticals. Currently Samson does not hold approved applications for all these products. Districts should contact CDER Import-Export Team if they have any questions about the regulatory status of the products. Note changed - 6/5/2007 63 - - - -- Human and Animal Drugs Date Published: 09/10/2009 Notes: All prescription drugs (finished dosage form) - 10/16/2006 Note: On December 1, 2005, a Warning Letter was issued to Samson Medical Technologies for importing and marketing unapproved antibiotic drug products. The products may be offered for entry labeled as �sterile bulk� and �For pharmacy compounding only�, although the articles are in fact finished pharmaceuticals. Currently Samson does not hold approved applications for all these products. Districts should contact CDER Import-Export Team if they have any questions about the regulatory status of the products. Note changed - 6/5/2007 64 - - - -- Human and Animal Drugs Date Published: 09/10/2009 Notes: All prescription drugs (finished dosage form) - 10/16/2006 Note: On December 1, 2005, a Warning Letter was issued to Samson Medical Technologies for importing and marketing unapproved antibiotic drug products. The products may be offered for entry labeled as �sterile bulk� and �For pharmacy compounding only�, although the articles are in fact finished pharmaceuticals. Currently Samson does not hold approved applications for all these products. Districts should contact CDER Import-Export Team if they have any questions about the regulatory status of the products. Note changed - 6/5/2007 65 - - - -- Human and Animal Drugs Date Published: 09/10/2009 Notes: All prescription drugs (finished dosage form) - 10/16/2006 Note: On December 1, 2005, a Warning Letter was issued to Samson Medical Technologies for importing and marketing unapproved antibiotic drug products. The products may be offered for entry labeled as �sterile bulk� and �For pharmacy compounding only�, although the articles are in fact finished pharmaceuticals. Currently Samson does not hold approved applications for all these products. Districts should contact CDER Import-Export Team if they have any questions about the regulatory status of the products. Note changed - 6/5/2007 66 - - - -- Human and Animal Drugs Date Published: 09/10/2009 Notes: All prescription drugs (finished dosage form) - 10/16/2006 Note: On December 1, 2005, a Warning Letter was issued to Samson Medical Technologies for importing and marketing unapproved antibiotic drug products. The products may be offered for entry labeled as �sterile bulk� and �For pharmacy compounding only�, although the articles are in fact finished pharmaceuticals. Currently Samson does not hold approved applications for all these products. Districts should contact CDER Import-Export Team if they have any questions about the regulatory status of the products. Note changed - 6/5/2007

— accessdata.fda.gov, retrieved 2026-08-06

Source

• accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_197.html

Last verified against source: 2026-08-06. Due for re-check by 2026-10-05. This page as Markdown · OKF bundle · full dataset as JSON.